Every investor in Hikma Pharmaceuticals PLC (LON:HIK) should be aware of the most powerful shareholder groups. We can see that institutions own the lion's share in the company with 52% ownership. Put ...
If you want to know who really controls Hikma Pharmaceuticals PLC (LON:HIK), then you'll have to look at the makeup of its share registry. We can see that institutions own the lion's share in the ...
Hikma Pharmaceuticals PLC closed 25.30% short of its 52-week high of £23.60, which the company reached on February 13th.
Hik-Connect 6, a cloud-based security software, continues to get better. The latest enhancements extend the reach of ‘Team Mode’ . This tool already provides security management across multiple ...
HANGZHOU, China, Oct. 24, 2023 /PRNewswire/ -- Hikvision has released an update for its security management platform Hik-Connect. The updated platform is also known as Hik-Connect for Teams, as the ...
Built on Hikvision's advanced large-scale AI models Guanlan, AcuSeek features sophisticated machine learning algorithms trained on millions of real-world scenarios. The technology's mechanisms enable ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Hikma Pharmaceuticals PLC closed 34.11% below its 52-week high of £23.60, which the company achieved on February 13th.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results